Literature DB >> 12686462

Total synthesis of human and rat coupling factor-6 amide and pressor effects in the rat.

J K Chang1, P Scruggs, J Yang, M Ouyang, A Duetzmann, N J Dun.   

Abstract

Mitochondrial coupling factor-6 (CF-6) is a component of the ATP synthase complex essential for energy transduction. CF-6, which is localized to the surface of endothelial cells (ECs) and released by shear stress, has been implicated as an endogenous vasoconstrictor. Previous methods of obtaining CF-6 through purification and recombinant methods were laborious and inefficient. Here, we describe the chemical synthesis of human CF-6, (33-108)-NH(2), its C-terminal fragment (55-108)-NH(2), which is termed pCF-6; the rat CF-6, (33-108)-NH(2), its C-terminal fragment pCF-6, (55-108)-NH(2); and two N-terminal fragments of the rat pro-coupling factor-6, (24-52)-NH(2) and (33-52)-NH(2). Biological activities of each peptide were initially screened with bioassays and verified by in vivo studies. Accordingly, intravenous administration of CF-6, pCF-6, rat CF-6, and rat pCF-6 produced a modest but statistically significant increase in blood pressure and heart rate in urethane anesthetized rats, whereas the N-terminal rat pro-coupling factor-6, (24-52)-NH(2) and (33-52)-NH(2) caused no significant pressor response. Thus, the biologically active site probably resides at the C-terminal portion of CF-6 peptides.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12686462     DOI: 10.1016/s0167-0115(02)00303-8

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  2 in total

Review 1.  Coupling factor 6 as a novel vasoactive and proatherogenic peptide in vascular endothelial cells.

Authors:  Tomohiro Osanai; Koji Magota; Ken Okumura
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-06-02       Impact factor: 3.000

2.  Over-expression of the ATP5J gene correlates with cell migration and 5-fluorouracil sensitivity in colorectal cancer.

Authors:  Hongbo Zhu; Linlin Chen; Wei Zhou; Zhongting Huang; Jingzi Hu; Sheng Dai; Xiaowei Wang; Xuefeng Huang; Chao He
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.